Product Details
| Product Name:
Zilovertamab |
CAS No.:
1643432-38-5 |
| Purity:
> 95% |
Supply Ability:
10g |
| Release date:
2024/11/19 |
Product Introduction
Bioactivity
| Name | Zilovertamab |
| Description | Zilovertamab (UC-961) is a humanized anti-ROR1 monoclonal antibody that cuts off the WNT5A-induced ROR1 signaling pathway and shows anti-proliferative activity in ovarian and endometrial cancer cells. It can be used to study lymphatic cancer. |
| In vitro | Zilovertamab (25 and 50 µg/mL; 72 h) inhibits the proliferation of high-grade serous ovarian cancer (HGSOC) cells[1].
Zilovertamab (50 µg/mL; 72 h) down-regulates the expression levels of ROR1 in CaOV3 at the transcriptional level[1]. |
| Storage | store at low temperature | store at -80°C | Shipping with blue ice. |
| Keywords | Zilovertamab | UC961 | UC 961 |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
-
CAS:201605-51-8
$293.00 / 1mg
-
CAS:1416561-90-4
$216.00 / 1mg
-
CAS:72021-23-9
$179.00 / 1mg
Recommended supplier
| Product name |
Price |
|
Suppliers |
Update time |
|
|
$/ |
|
Anhui Ruihan Technology Co., Ltd
|
2023-08-21 |
United States